Clinical Trial Update: Randomization of Botox for Stent Pain and Irritative Voiding Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial investigating Botox for stent pain and irritative voiding symptoms has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Urinary Tract Discomfort
• Stent Pain

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of California, Irvine | Conditions: Lower Urinary Tract Discomfort, Stent Pain | Phase 3 | Status: TERMINATED